Sort
21,453 grants matching “tuberculosis”
Immunotherapeutic nanoparticles: Implications for the treatment of tuberculosis and HIV
$201,250Jessica L Reynolds · State University Of New York At Buffalo · R21 · FY2024 · AI
Mapping of the IgM and IgG antibody responses to Talaromyces marneffei infection in mice and humans - Deciphering acute from reactivated or latent infections
$201,250Thuy Le · Duke University · R21 · FY2022 · AI
Noncompetitive inhibition of CYP121 dimers from Mycobacterium tuberculosis
$201,250David Fernando Estrada · State University Of New York At Buffalo · R21 · FY2025 · AI
A Novel Mechanism of Innate Immunity Against TB
$201,250Brigham And Women'S Hospital · R01 · FY2002 · AI
Multiplexed point-of-care molecular detection for multiple infections in co-endemic settings
$201,250Robert M Greenberg · University Of Pennsylvania · R21 · FY2018 · AI
GAIT complex formation and Mycobacterium tuberculosis
$201,250Liem Duy Nguyen · Case Western Reserve University · R21 · FY2022 · AI
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$201,213Jessica L Castilho · Vanderbilt University Medical Center · U01 · FY2025 · AI
Mycobacterial determinants of escape from pathogen-specific immunity
$201,160Allison Carey · Massachusetts General Hospital · K08 · FY2019 · AI
Mycobacterial determinants of escape from pathogen-specific immunity
$201,160Allison Carey · Massachusetts General Hospital · K08 · FY2020 · AI
Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIV
$201,150Christopher Allen Berger · University Of California, San Francisco · K23 · FY2022 · HL
Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIV
$201,150Christopher Allen Berger · University Of California, San Francisco · K23 · FY2021 · HL
Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIV
$201,150Christopher Allen Berger · University Of California, San Francisco · K23 · FY2024 · HL
Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIV
$201,150Christopher Allen Berger · University Of California, San Francisco · K23 · FY2025 · HL
Digital adherence technologies to facilitate completion of short-course tuberculosis preventive therapy among people living with HIV
$201,150Christopher Allen Berger · University Of California, San Francisco · K23 · FY2023 · HL
Origins of zinc starvation in Mycobacterium tuberculosis during chronic infection
$201,128Anil Kumar Ojha · Wadsworth Center · R21 · FY2022 · AI
Protein Expression and Antibody Development
$201,113Timothy A Cross · Florida State University · P01 · FY2010 · AI
Determinants of antigen specific CD4 T cell function in tuberculosis
$201,066Tyler Dallas Bold · University Of Minnesota · K08 · FY2021 · AI
Determinants of antigen specific CD4 T cell function in tuberculosis
$201,066Tyler Dallas Bold · University Of Minnesota · K08 · FY2022 · AI
Molecular Mechanisms of Mechanosensitive Channel Gating
$200,950Paul L Blount · Ut Southwestern Medical Center · R01 · FY2017 · GM
Molecular Mechanisms of Mechanosensitive Channel Gating
$200,950Paul L Blount · Ut Southwestern Medical Center · R01 · FY2016 · GM
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
$200,932Anushka Naidoo · Centre/Aids Programme/Res/South Africa · R01 · FY2024 · AI
Mycobacterial determinants of escape from pathogen-specific immunity
$200,932Allison Carey · Massachusetts General Hospital · K08 · FY2018 · AI
Innovative Approaches for Tuberculosis Control in Brazil
$200,925Richard E Chaisson · Johns Hopkins University · U2R · FY2008 · TW
CATALASE-PEROXIDASE CATALYSIS IN ANTIBIOTIC ACTIVATION
$200,915Brooklyn College · R01 · FY2001 · AI
Functional and Molecular Analysis of Scout Cell Awakening
$200,890Slava Simon Epstein · Northeastern University · R21 · FY2014 · AI